Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Bridging Radiotherapy May Decrease Inflammation Prior to CAR-T Cell Therapy

Roshal R. Patel, Alexander Tward, Beatrice Fregonese, Harper Hubbeling, Kaitlyn Lapen, Nikhil P. Mankuzhy, Sandeep S. Raj, Miguel-Angel Perales, Roni Shouval, Joachim Yahalom, Brandon S. Imber

Blood (2024) 144 (Supplement 1): 7164.

https://doi.org/10.1182/blood-2024-210814

Published: 2024

Journal Articles

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Gustav Cederquist, Kathryn Tringale, Carla Hajj, Harper Hubbeling, Jennifer Ma, Alexandra Dreyfuss, Beatrice Fregonese, Gilles Salles, Christian Grommes, Michael Scordo, Lorenzo Falchi, Joachim Yahalom, Brandon S. Imber

Blood (2023) 142 (Supplement 1): 1759.

https://doi.org/10.1182/blood-2023-190236

Published: 2023

Journal Articles

CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 4491.

https://doi.org/10.1182/blood-2023-190326

Published: 2023

Journal Articles

Dynamics of Radiomic Features Following Bridging Therapy Determine CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome

Blood (2023) 142 (Supplement 1): 2123.

https://doi.org/10.1182/blood-2023-187763

Published: 2023

Journal Articles

18F-FDG PET/CT Imaging Biomarkers for CAR-T Cell Therapy Outcomes in Large-B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1639.

https://doi.org/10.1182/blood-2023-179641

Published: 2023

Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2023-185338

Published: 2023

Journal Articles

Radiotherapy for Secondary CNS Lymphoma: Patterns of Utilization and Clinical Outcomes

Gustav Y Cederquist, Kathryn R. Tringale, Carla Hajj, Harper Hubbeling, Beatrice Fregonese, Jisun Lee, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon S. Imber

Blood (2022) 140 (Supplement 1): 6683–6684.

https://doi.org/10.1182/blood-2022-170191

Published: 2022

Journal Articles

Safety and Efficacy of Splenic Irradiation for Non-Hodgkin Lymphoma

Harper Hubbeling, Brandon S. Imber, N. Ari Wijetunga, Kathryn R. Tringale, Carla Hajj, Joachim Yahalom

Blood (2022) 140 (Supplement 1): 9538–9539.

https://doi.org/10.1182/blood-2022-167084

Published: 2022

Journal Articles

Initial Treatment Response Is Prognostic and Predictive of Relapse Patterns: Outcomes of >500 Patients Treated for Primary CNS Lymphoma

Kathryn R. Tringale, Joachim Yahalom, Michael Scordo, Gustav Y Cederquist, Behroze Vachha, Lauren Schaff, Carla Hajj, Harper Hubbeling, Zhigang Zhang, Charlie White, Christian Grommes, Brandon S. Imber

Blood (2022) 140 (Supplement 1): 1336–1337.

https://doi.org/10.1182/blood-2022-164663

Published: 2022

Journal Articles

Primary Hepatic Lymphoma: Role of Low-Dose Radiotherapy at a Single Institution with Genetic Characterization and Paired Literature Review

Jennifer Ma, Remy Daou, Josiane Bou Eid, Jisun Lee, Beatrice Fregonese, Joe El-Khoury, Neil Ari Wijetunga, Harper Hubbeling, Kathryn R. Tringale, Emily S. Lebow, Reith Sarkar, Brandon S. Imber, Joachim Yahalom, Carla Hajj

Blood (2022) 140 (Supplement 1): 11949–11950.

https://doi.org/10.1182/blood-2022-162623

Published: 2022

Journal Articles

Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma

Neil Ari Wijetunga, Emily S. Lebow, Jisun Lee, Beatrice Fregonese, Kathryn R. Tringale, Harper Hubbeling, Reith Sarkar, Jennifer Ma, Venkatraman Seshan, Erel Joffe, Ahmet Dogan, Alexander Chan, Guido Wendel, Carla Hajj, Brandon S. Imber, Joachim Yahalom

Blood (2022) 140 (Supplement 1): 6413–6414.

https://doi.org/10.1182/blood-2022-169501

Published: 2022

Journal Articles

"Big Boom" (4 Gy x 1) Radiation Treatment (RT) Versus "Big Boom" (2 Gy x 2) for Non-Hodgkin Lymphoma (NHL)

Carla Hajj, Emily S. Lebow, Jisun Lee, Beatrice Fregonese, N. Ari Wijetunga, Harper Hubbeling, Kathryn R. Tringale, Morgan E. Freret, Brandon S. Imber, Joachim Yahalom

Blood (2022) 140 (Supplement 1): 3622–3623.

https://doi.org/10.1182/blood-2022-160246

Published: 2022

Journal Articles

Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center

Blood (2021) 138 (Supplement 1): 2507.

https://doi.org/10.1182/blood-2021-151179

Published: 2021

Journal Articles

Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy

Blood (2021) 138 (Supplement 1): 1429.

https://doi.org/10.1182/blood-2021-149702

Published: 2021

Journal Articles

Patrolling Murine Monocytes Are Defined by Their Expression of the Orphan Nuclear Receptor, Nur77 (nr4a1)

Harper Hubbeling, Jonathan Maltzman, MD, PhD, Amy Moran, Kristin Hogquist, PhD, Nicole Cunningham, Jenni A. Punt, VMD, PhD

Blood (2010) 116 (21): 4723.

https://doi.org/10.1182/blood.V116.21.4723.4723

Published: 2010

Journal Articles

Characterization of Nur77+ Cells in Murine Peripheral Blood.

Harper Hubbeling, undergraduate, Thomas Beck, undergraduate, Amy Moran, graduate, student, Kristin Hogquist, PhD, Jonathan Maltzman, MD, PhD, Nicole Cunningham, research, associate, Jenni Punt, VMD, PhD

Blood (2009) 114 (22): 1361.

https://doi.org/10.1182/blood.V114.22.1361.1361

Published: 2009

NARROW

Bridging Radiotherapy May Decrease Inflammation Prior to CAR-T Cell Therapy

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

Dynamics of Radiomic Features Following Bridging Therapy Determine CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome

18F-FDG PET/CT Imaging Biomarkers for CAR-T Cell Therapy Outcomes in Large-B-Cell Lymphoma

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

Radiotherapy for Secondary CNS Lymphoma: Patterns of Utilization and Clinical Outcomes

Safety and Efficacy of Splenic Irradiation for Non-Hodgkin Lymphoma

Initial Treatment Response Is Prognostic and Predictive of Relapse Patterns: Outcomes of >500 Patients Treated for Primary CNS Lymphoma

Primary Hepatic Lymphoma: Role of Low-Dose Radiotherapy at a Single Institution with Genetic Characterization and Paired Literature Review

Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma

"Big Boom" (4 Gy x 1) Radiation Treatment (RT) Versus "Big Boom" (2 Gy x 2) for Non-Hodgkin Lymphoma (NHL)

Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center

Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy

Patrolling Murine Monocytes Are Defined by Their Expression of the Orphan Nuclear Receptor, Nur77 (nr4a1)

Characterization of Nur77+ Cells in Murine Peripheral Blood.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only